Adverse Effects Associated with Patient-Controlled Analgesia with Ketamine Combined with Opioids and Ketamine Infusion with PCA Bolus in Postoperative Spine Patients: A Retrospective Review

Tiffany M Pouldar, Dermot P Maher, Alexander W Betz, Jeffrey J Wiegers, Jeremy A Friedman, Sameer S Zaidi, Ali Rejali, Hai P Tran, Roya Yumul, Charles Louy, Tiffany M Pouldar, Dermot P Maher, Alexander W Betz, Jeffrey J Wiegers, Jeremy A Friedman, Sameer S Zaidi, Ali Rejali, Hai P Tran, Roya Yumul, Charles Louy

Abstract

Objective: There has been increasing use of ketamine at subanesthetic doses as an adjunct to opioids in perioperative pain management. There are several known adverse drug effects (ADEs) associated with ketamine. However, the incidence of ADEs with ketamine infusions with patient-controlled analgesia (PCA) boluses compared with combined opioid and ketamine PCAs is not well described. The objectives of this study were to compare the incidence and type of ADEs in postoperative spine surgery patients on ketamine infusions with as-needed PCA boluses to patients on combined opioid and ketamine PCAs.

Methods: The medical records of patients who underwent spine surgery between March 2016 and March 2020 who were postoperatively treated with a ketamine infusion and as-needed PCA boluses and parenteral opioids or treated with a combined opioid and ketamine PCA were reviewed. Perioperative information including patient characteristics and preoperative morphine equivalent daily dose (MEDD) were collected. Patient charts were reviewed for ADEs including psychological and neurological side effects, nausea, and new-onset tachycardia.

Results: A total of 315 patients met the inclusion criteria and were included in the final analysis. Of these patients, 121 experienced at least one ADE (38%). Sixteen of the 68 ketamine infusion with PCA bolus patients (24%), 77 of the 203 hydromorphone and ketamine patients (38%), and 28 of the 44 morphine and ketamine patients (64%) experienced an ADE [p<0.01]. In patients with preoperative MEDD ≤ 90, nausea was the only ADE that differed significantly among the three groups.

Conclusion: This retrospective analysis suggests that postoperative spine patients treated with a ketamine infusion with as-needed PCA boluses and parenteral opioids were associated with fewer ADEs when compared to an intravenous combined opioid and ketamine PCA. In patients with preoperative MEDD ≤ 90, nausea with and without emesis was the only ADE that showed statistically significant difference amongst the three groups.

Keywords: adverse drug effects; ketamine; opioid; patient-controlled analgesia; postoperative; retrospective.

Conflict of interest statement

The authors report no conflicts of interest in this work.

© 2022 Pouldar et al.

References

    1. Cohen SP, Bhatia A, Buvanendran A, et al. Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018;43(5):521–546. doi:10.1097/AAP.0000000000000808
    1. Gorlin AW, Rosenfeld DM, Ramakrishna H. Intravenous sub-anesthetic ketamine for perioperative analgesia. J Anaesthesiol Clin Pharmacol. 2016;32(2):160–167. doi:10.4103/0970-9185.182085
    1. Porter SB, McClain RL, Howe BL, et al. Perioperative ketamine for acute postoperative analgesia: the Mayo Clinic-Florida experience. J Perianesth Nurs. 2015;30(3):189–195. doi:10.1016/j.jopan.2015.01.010
    1. Schwenk ES, Viscusi ER, Buvanendran A, et al. Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018;43(5):456–466. doi:10.1097/AAP.0000000000000806
    1. Pendi A, Field R, Farhan SD, Eichler M, Bederman SS. Perioperative ketamine for analgesia in spine surgery: a meta-analysis of randomized controlled trials. Spine. 2018;43(5):E299–E307. doi:10.1097/BRS.0000000000002318
    1. Loftus RW, Yeager MP, Clark JA, et al. Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery. Anesthesiology. 2010;113(3):639–646. doi:10.1097/ALN.0b013e3181e90914
    1. Jouguelet-Lacoste J, La CL, Schilling D, Chelly JE. The use of intravenous infusion or single dose of low-dose ketamine for postoperative analgesia: a review of the current literature. Pain Med. 2015;16(2):383–403. doi:10.1111/pme.12619
    1. Adriaenssens G, Vermeyen KM, Hoffmann VL, Mertens E, Adriaensen HF. Postoperative analgesia with i.v. patient-controlled morphine: effect of adding ketamine. Br J Anaesth. 1999;83(3):393–396. doi:10.1093/bja/83.3.393
    1. Wang L, Johnston B, Kaushal A, Cheng D, Zhu F, Martin J. Ketamine added to morphine or hydromorphone patient-controlled analgesia for acute postoperative pain in adults: a systematic review and meta-analysis of randomized trials. Can J Anaesth. 2016;63(3):311–325. doi:10.1007/s12630-015-0551-4
    1. Assouline B, Tramer MR, Kreienbuhl L, Elia N. Benefit and harm of adding ketamine to an opioid in a patient-controlled analgesia device for the control of postoperative pain: systematic review and meta-analyses of randomized controlled trials with trial sequential analyses. Pain. 2016;157(12):2854–2864. doi:10.1097/j.pain.0000000000000705
    1. Schwenk ES, Goldberg SF, Patel RD, et al. Adverse drug effects and preoperative medication factors related to perioperative low-dose ketamine infusions. Reg Anesth Pain Med. 2016;41(4):482–487. doi:10.1097/AAP.0000000000000416
    1. Gil LV, Mazzeffi MA, Cai Y, McLeod WW, Porter SB. Reasons for discontinuation of acute postoperative pain ketamine infusions: a retrospective case-control study. Pain Pract. 2021;21(7):759–765. doi:10.1111/papr.13012
    1. Waelkens P, Alsabbagh E, Sauter A, et al. Pain management after complex spine surgery: a systematic review and procedure-specific postoperative pain management recommendations. Eur J Anaesthesiol. 2021;38(9):985–994. doi:10.1097/EJA.0000000000001448
    1. Treede RD, Rief W, Barke A, et al. A classification of chronic pain for ICD-11. Pain. 2015;156(6):1003–1007. doi:10.1097/j.pain.0000000000000160
    1. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49. doi:10.15585/mmwr.rr6501e1
    1. Laskowski K, Stirling A, McKay WP, Lim HJ. A systematic review of intravenous ketamine for postoperative analgesia. Can J Anaesth. 2011;58(10):911–923. doi:10.1007/s12630-011-9560-0
    1. Avidan MS, Maybrier HR, Abdallah AB, et al. Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial. Lancet. 2017;390(10091):267–275. doi:10.1016/S0140-6736(17)31467-8
    1. Michelet P, Guervilly C, Helaine A, et al. Adding ketamine to morphine for patient-controlled analgesia after thoracic surgery: influence on morphine consumption, respiratory function, and nocturnal desaturation. Br J Anaesth. 2007;99(3):396–403. doi:10.1093/bja/aem168
    1. Dahi-Taleghani M, Fazli B, Ghasemi M, Vosoughian M, Dabbagh A. Effect of intravenous patient controlled ketamine analgesia on postoperative pain in opium abusers. Anesth Pain Med. 2014;4(1):e14129. doi:10.5812/aapm.14129
    1. Nielsen RV, Fomsgaard JS, Siegel H, et al. Intraoperative ketamine reduces immediate postoperative opioid consumption after spinal fusion surgery in chronic pain patients with opioid dependency: a randomized, blinded trial. Pain. 2017;158(3):463–470. doi:10.1097/j.pain.0000000000000782
    1. Sveticic G, Eichenberger U, Curatolo M. Safety of mixture of morphine with ketamine for postoperative patient-controlled analgesia: an audit with 1026 patients. Acta Anaesthesiol Scand. 2005;49(6):870–875. doi:10.1111/j.1399-6576.2005.00740.x
    1. Subramaniam K, Akhouri V, Glazer PA, et al. Intra- and postoperative very low dose intravenous ketamine infusion does not increase pain relief after major spine surgery in patients with preoperative narcotic analgesic intake. Pain Med. 2011;12(8):1276–1283. doi:10.1111/j.1526-4637.2011.01144.x
    1. Stoker AD, Rosenfeld DM, Buras MR, Alvord JM, Gorlin AW. Evaluation of clinical factors associated with adverse drug events in patients receiving sub-anesthetic ketamine infusions. J Pain Res. 2019;12:3413–3421. doi:10.2147/JPR.S217005
    1. Rasmussen KG. Psychiatric side effects of ketamine in hospitalized medical patients administered subanesthetic doses for pain control. Acta Neuropsychiatr. 2014;26(4):230–233. doi:10.1017/neu.2013.61
    1. Lin J, Figuerado Y, Montgomery A, et al. Efficacy of ketamine for initial control of acute agitation in the emergency department: a randomized study. Am J Emerg Med. 2021;44:306–311. doi:10.1016/j.ajem.2020.04.013
    1. Blake DW, Korner PI. Role of baroreceptor reflexes in the hemodynamic and heart rate responses to althesin, ketamine and thiopentone anesthesia. J Auton Nerv Syst. 1981;3(1):55–70. doi:10.1016/0165-1838(81)90030-8

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다